Marinus van Hulst

969 total citations
59 papers, 666 citations indexed

About

Marinus van Hulst is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Management of Technology and Innovation. According to data from OpenAlex, Marinus van Hulst has authored 59 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 18 papers in Epidemiology and 12 papers in Management of Technology and Innovation. Recurrent topics in Marinus van Hulst's work include Atrial Fibrillation Management and Outcomes (16 papers), Blood donation and transfusion practices (12 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Marinus van Hulst is often cited by papers focused on Atrial Fibrillation Management and Outcomes (16 papers), Blood donation and transfusion practices (12 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). Marinus van Hulst collaborates with scholars based in Netherlands, Zimbabwe and United Kingdom. Marinus van Hulst's co-authors include Maarten J. Postma, Robert G Tieleman, Dirkje S. Postma, René Aalbers, Johan Zaagsma, H. J. van der Woude, J. Th. M. de Wolf, Nyashadzaishe Mafirakureva, Femke Kaasenbrood and Cees Th. Smit Sibinga and has published in prestigious journals such as PLoS ONE, CHEST Journal and International Journal of Environmental Research and Public Health.

In The Last Decade

Marinus van Hulst

58 papers receiving 641 citations

Peers

Marinus van Hulst
Cynthia B. Snider United States
Alison Deary United Kingdom
Lene Russell Denmark
Kathleen Sazama United States
Alexandra Savinkina United States
Kwamena William Coleman Sagoe Ghana
Kjell Titlestad Denmark
Sarah Ward Canada
Bamlaku Enawgaw Ethiopia
Nandini Selvam United States
Cynthia B. Snider United States
Marinus van Hulst
Citations per year, relative to Marinus van Hulst Marinus van Hulst (= 1×) peers Cynthia B. Snider

Countries citing papers authored by Marinus van Hulst

Since Specialization
Citations

This map shows the geographic impact of Marinus van Hulst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marinus van Hulst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marinus van Hulst more than expected).

Fields of papers citing papers by Marinus van Hulst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marinus van Hulst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marinus van Hulst. The network helps show where Marinus van Hulst may publish in the future.

Co-authorship network of co-authors of Marinus van Hulst

This figure shows the co-authorship network connecting the top 25 collaborators of Marinus van Hulst. A scholar is included among the top collaborators of Marinus van Hulst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marinus van Hulst. Marinus van Hulst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katsidzira, Leolin, et al.. (2025). Cost-Effectiveness of Screening and Treating Chronic Hepatitis C Virus Infection in Zimbabwe. International Journal of Environmental Research and Public Health. 22(4). 509–509.
2.
3.
4.
Hulst, Marinus van, et al.. (2023). Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland. The European Journal of Health Economics. 25(4). 689–699. 6 indexed citations
5.
Loef, Bert G., et al.. (2023). The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin. Research and Practice in Thrombosis and Haemostasis. 7(4). 100185–100185. 2 indexed citations
6.
Postma, Maarten J., et al.. (2022). Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia. Vaccine. 40(14). 2161–2167. 4 indexed citations
7.
Postma, Maarten J., et al.. (2022). Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups. The European Journal of Health Economics. 23(7). 1221–1227. 9 indexed citations
8.
Hulst, Marinus van, et al.. (2021). Unintentional ingestion of a high dose of acenocoumarol in a young child. BMJ Case Reports. 14(4). e240365–e240365. 2 indexed citations
9.
10.
Adeoye, Abiodun M., et al.. (2021). Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria. Global Heart. 16(1). 80–80. 2 indexed citations
11.
Hulst, Marinus van, et al.. (2021). Persistent Socioeconomic Inequalities in Measles Vaccine Uptake in Ethiopia in the Period 2005 to 2016. Value in Health Regional Issues. 25. 71–79. 2 indexed citations
12.
Velden, Annette W.G. van der, et al.. (2020). Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism. BMJ Open. 10(11). e039057–e039057. 11 indexed citations
13.
14.
Kaasenbrood, Femke, et al.. (2016). Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands. EP Europace. 20(1). euw285–euw285. 70 indexed citations
15.
Gonese, Elizabeth, Janet Dzangare, Simbarashe Rusakaniko, et al.. (2015). Within-Gender Changes in HIV Prevalence among Adults between 2005/6 and 2010/11 in Zimbabwe. PLoS ONE. 10(7). e0129611–e0129611. 8 indexed citations
16.
Mafirakureva, Nyashadzaishe, et al.. (2014). Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis.. PubMed. 12(3). 362–7. 24 indexed citations
17.
Mafirakureva, Nyashadzaishe, et al.. (2013). Poster Abstracts. Vox Sanguinis. 105(s1). 65–299. 4 indexed citations
18.
19.
Tu, Hong, Robin de Vries, Herman J. Woerdenbag, et al.. (2012). Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making. Value in Health Regional Issues. 1(1). 7–14. 14 indexed citations
20.
Hulst, Marinus van, et al.. (2002). Pharmaco‐economics of blood transfusion safety: review of the available evidence. Vox Sanguinis. 83(2). 146–155. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia B. Snider Breakdown of academic impact, for papers by Alison Deary Breakdown of academic impact, for papers by Lene Russell Breakdown of academic impact, for papers by Kathleen Sazama Breakdown of academic impact, for papers by Alexandra Savinkina Breakdown of academic impact, for papers by Kwamena William Coleman Sagoe Breakdown of academic impact, for papers by Kjell Titlestad Breakdown of academic impact, for papers by Sarah Ward Breakdown of academic impact, for papers by Bamlaku Enawgaw Breakdown of academic impact, for papers by Nandini Selvam
Rankless by CCL
2026